Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aldo451on Jun 08, 2020 7:44pm
122 Views
Post# 31126667

RE:RE:Liminal Executive Compensation - Part 2

RE:RE:Liminal Executive Compensation - Part 2I would also like to hear about the AGM if anyone would share.

Regarding compensation, here is the link for the Sedar document. Executive compensation can be found on pages 114-117. This is much better than what I tried to convey..lol.

https://www.sedar.com/GetFile.do?lang=EN&docClass=7&issuerNo=00004497&issuerType=03&projectNo=03031518&docId=4687049


<< Previous
Bullboard Posts
Next >>